UPDATE 2
PUTRAJAYA, Aug 11 — Six more people have died of Influenza A(H1N1), bringing to 38 the total number of deaths from the disease in the country, Director-General of Health Tan Sri Dr Mohd Ismail Merican said today.
The number of cases has climbed to 2,253 with 270 new cases from local transmission reported nationwide yesterday, he told a news conference, here.
“Of the six people who died, four were in the high-risk category and suffered from ailments such as diabetes, high-blood pressure and asthma,” he said. One of the six died on Aug 4, two on Aug 6 and three on Aug 7, he added.
Dr Mohd Ismail said 48 people had been warded in hospitals throughout the country and 11 more were in the Intensive Care Unit (ICU), four of whom were in the high-risk category.
He advised the public to heed Prime Minister Datuk Seri Najib Razak’s suggestion yesterday to stay at home should they find themselves developing flu-like symptoms and avoid going to public places without a face mask.
“I visited many (public) places and also got feedback from friends that many people were found coughing in public places but they did not use masks.
“The disease is very contagious. That is why a lot of people are getting it,” Dr Mohd Ismail reminded the public.
On the capacity of state hospitals to run H1N1 tests, he said these hospitals were expected to do so in two weeks’ time although the Rapid Test can be deployed almost immediately.
“The Rapid Test is useful to some extent because it can tell whether you have A or B or C flu. That’s all it does. We say if you have A, chances are you have H1N1.
“If you don’t have A flu, it doesn’t mean you don’t have A flu because of its limitation. Rapid Test is cheaper, easier to do with faster results. That’s why we’ll introduce it to the clinics. H1N1 tests are for those admitted to hospitals as it is more intensive,” he said.
Dr Mohd Ismail advised medical practitioners to keep an eye out for a patient’s respiratory rate and lung condition as these were danger signs for death-related incidents.
He also advised patients in the home to monitor their health condition, and if they had symptoms such as rapid breathing, shortness of breath, breathing difficulty or chest pains to seek treatment immediately.
He reminded clinics and private hospitals not to turn away patients seeking treatment as they now had access to stockpiles of the antiviral drug Tamiflu, and asked patients to put on a mask when seeking treatment to avoid infecting other patients in the hospital.
On the possibility of school closures, he said: “We have discussed the matter with the Education Ministry, and would not close schools indiscriminately.
“The director-general of education and I concur on this. Should there be any incident, we will send a health team to make an examination and report back to me,” he said.
Dr Mohd Ismail said he was appalled that not enough liquid soap was provided at public places and toilets, including at airports and highway rest areas, adding that such unsanitary and unhygienic conditions could cause the disease to spread.
On a global scale, up till today, there have been 208,990 cases with 1,716 deaths reported in 174 countries, up by 835 cases and 28 deaths compared to yesterday. – Bernama





Relative of the A (H1N1) patient
Laninamivir (CS-8958) is a neuraminidase inhibitor which is being researched for the treatment and prophylaxis of Influenzavirus A and Influenzavirus B. It is currently in Phase III clinical trials
1.Yamashita M, Tomozawa T, Kakuta M, Tokumitsu A, Nasu H, Kubo S (January 2009). "CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity". Antimicrobial Agents and Chemotherapy 53 (1): 186–92. doi:10.1128/AAC.00333-08. PMID 18955520.
2.Hayden F (January 2009). "Developing new antiviral agents for influenza treatment: what does the future hold?". Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America 48 Suppl 1: S3–13. doi:10.1086/591851. PMID 19067613
It has the same effect as current Tamiflu and is even more effective for children. It is developed by Daiichi Sankyo Company, Japan.
So MOH DG was wrong and short sighted to advise his minister, PM and DPM to block the antiviral medicine from the GPs and patients. Now also after repeated assurance of supplying them, up to 11.30 AM 11.00 of Aug 2009, we could not even buy the medicine.
His lame excuse of overuse leading to drug resistance is invalid as other countries are using almost indiscriminately. Malaysians are denied early treatment and facing death because this medicine is most effective in first two days only.
I am a doctor, old, got HPT, Asthma, Hypercholesterolemia and have VMR. Because my sister doctor was diagnosed positive but late for treatment, as I am exposed, I had consulted the kind-hearted professor of my sister. My temperature was 37.8 and my Asthma was not relieved even after inhaling various inhalers for about 2 dozens of time. As X-ray is normal MOH refused throat swab. The Prof. decided to give me Tamiflu. Within 1-2 hrs I feel almost normal. Able to stop all other Asthma medicine , painkillers and fever medicine. TQ Professor for farsightedness and not following the stupid orders of MOH.
MOH DH should take responsibility and resign gracefully or dismissed.